Intervention

Pancreatic Polypeptide (PP)

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy HumansNCT07506369 · 2026-04-01

The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic PatientsNCT00791076 · 2007-10-01

Common conditions

Diabetes Mellitus, Type 11 Obesity & Overweight1

Leading sponsors

Johns Hopkins University1 University Hospital, Gentofte, Copenhagen1

Trial status mix

RECRUITING1

TERMINATED1

Phase mix

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.